| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2221 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-64 |
| filingDate |
2019-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a4c99eb8ccdf8f37ad90cfd2b49e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d7ef26af339475234f4b5c8049218c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba622c59078c5629f03e3d7f61af59ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84eb953ad38bb8a388454dcac940ef3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d05b0206ec6741085902afaf5cfe6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c06beca94603d27d4b1e8238330c70ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d73fcb874e44baf0ca077e8154b3841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96d8e1c719ef7e3fed8801575b70dc35 |
| publicationDate |
2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019149782-A1 |
| titleOfInvention |
Modified lipidated relaxin b chain peptides and their therapeutic use |
| abstract |
The present invention relates to a biologically active single chain Relaxin peptide having the following formula (I): Nter-Ac-X10-E-G-R-E-X15-V-R-X18-X19-I-X21-X22-E-G-X25-S-X27-X28-X29-X30-X31-X32-X33-NH2-Cter or a salt or solvate thereof. It also concerns a pharmaceutical composition comprising at least one peptide of the invention, and the peptide or the pharmaceutical composition for its use as a medicament. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961295-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364281-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11725036-B2 |
| priorityDate |
2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |